Exact Mass: 525.4757

Exact Mass Matches: 525.4757

Found 199 metabolites which its exact mass value is equals to given mass value 525.4757, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

19-Methyltetracosanoylcarnitine

3-[(19-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4757)


19-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 19-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 19-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 19-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

7-Methyltetracosanoylcarnitine

3-[(7-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4757)


7-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 7-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 7-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 7-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

20-Methyltetracosanoylcarnitine

3-[(20-Methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C32H63NO4 (525.4757)


20-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 20-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 20-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 20-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Methyltetracosanoylcarnitine

3-[(3-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4757)


3-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 3-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 3-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

9-Methyltetracosanoylcarnitine

3-[(9-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4757)


9-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 9-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 9-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 9-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

15-Methyltetracosanoylcarnitine

3-[(15-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4757)


15-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 15-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 15-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 15-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

23-Methyltetracosanoylcarnitine

3-[(23-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4757)


23-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 23-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 23-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 23-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

16-Methyltetracosanoylcarnitine

3-[(16-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4757)


16-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 16-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 16-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 16-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

13-Methyltetracosanoylcarnitine

3-[(13-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4757)


13-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 13-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 13-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 13-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

10-Methyltetracosanoylcarnitine

3-[(10-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4757)


10-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 10-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 10-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 10-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

17-Methyltetracosanoylcarnitine

3-[(17-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4757)


17-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 17-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 17-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 17-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

21-Methyltetracosanoylcarnitine

3-[(21-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4757)


21-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 21-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 21-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 21-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

22-Methyltetracosanoylcarnitine

3-[(22-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4757)


22-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 22-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 22-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 22-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Methyltetracosanoylcarnitine

3-[(5-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4757)


5-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 5-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 5-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

14-Methyltetracosanoylcarnitine

3-[(14-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4757)


14-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 14-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 14-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 14-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

8-Methyltetracosanoylcarnitine

3-[(8-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4757)


8-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 8-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 8-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 8-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

6-Methyltetracosanoylcarnitine

3-[(6-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4757)


6-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 6-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 6-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 6-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

4-Methyltetracosanoylcarnitine

3-[(4-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4757)


4-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 4-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 4-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

18-Methyltetracosanoylcarnitine

3-[(18-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4757)


18-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 18-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 18-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 18-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

11-Methyltetracosanoylcarnitine

3-[(11-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4757)


11-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 11-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 11-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 11-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

12-Methyltetracosanoylcarnitine

3-[(12-methyltetracosanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4757)


12-Methyltetracosanoylcarnitine is an acylcarnitine. More specifically, it is an 12-methyltetracosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 12-Methyltetracosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine 12-Methyltetracosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Pentacosanoylcarnitine

3-(pentacosanoyloxy)-4-(trimethylazaniumyl)butanoate

C32H63NO4 (525.4757)


Pentacosanoylcarnitine is an acylcarnitine. More specifically, it is an pentacosanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Pentacosanoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine Pentacosanoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Cer(d18:0/15:0)

N-(pentadecanoyl)-sphinganine

C33H67NO3 (525.5121)


   

Cer 32:1;O3

N-(tetradecanoyl)-6R-hydroxy-sphing-4E-enine

C32H63NO4 (525.4757)


   

Cer[AS]

N-(2-hydroxy-tetradecanoyl)-sphing-4-enine

C32H63NO4 (525.4757)


   

Cer[NdS]

N-(pentadecanoyl)-sphinganine

C33H67NO3 (525.5121)


   

1,1,1,3,3,3-Hexabromoacetone

1,1,1,3,3,3-Hexabromoacetone

C3Br6O (525.5049)


   

Pentacosanoylcarnitine

Pentacosanoylcarnitine

C32H63NO4 (525.4757)


   

7-Methyltetracosanoylcarnitine

7-Methyltetracosanoylcarnitine

C32H63NO4 (525.4757)


   

3-Methyltetracosanoylcarnitine

3-Methyltetracosanoylcarnitine

C32H63NO4 (525.4757)


   

9-Methyltetracosanoylcarnitine

9-Methyltetracosanoylcarnitine

C32H63NO4 (525.4757)


   

5-Methyltetracosanoylcarnitine

5-Methyltetracosanoylcarnitine

C32H63NO4 (525.4757)


   

8-Methyltetracosanoylcarnitine

8-Methyltetracosanoylcarnitine

C32H63NO4 (525.4757)


   

6-Methyltetracosanoylcarnitine

6-Methyltetracosanoylcarnitine

C32H63NO4 (525.4757)


   

4-Methyltetracosanoylcarnitine

4-Methyltetracosanoylcarnitine

C32H63NO4 (525.4757)


   

19-Methyltetracosanoylcarnitine

19-Methyltetracosanoylcarnitine

C32H63NO4 (525.4757)


   

20-Methyltetracosanoylcarnitine

20-Methyltetracosanoylcarnitine

C32H63NO4 (525.4757)


   

15-Methyltetracosanoylcarnitine

15-Methyltetracosanoylcarnitine

C32H63NO4 (525.4757)


   

23-Methyltetracosanoylcarnitine

23-Methyltetracosanoylcarnitine

C32H63NO4 (525.4757)


   

16-Methyltetracosanoylcarnitine

16-Methyltetracosanoylcarnitine

C32H63NO4 (525.4757)


   

13-Methyltetracosanoylcarnitine

13-Methyltetracosanoylcarnitine

C32H63NO4 (525.4757)


   

10-Methyltetracosanoylcarnitine

10-Methyltetracosanoylcarnitine

C32H63NO4 (525.4757)


   

17-Methyltetracosanoylcarnitine

17-Methyltetracosanoylcarnitine

C32H63NO4 (525.4757)


   

21-Methyltetracosanoylcarnitine

21-Methyltetracosanoylcarnitine

C32H63NO4 (525.4757)


   

22-Methyltetracosanoylcarnitine

22-Methyltetracosanoylcarnitine

C32H63NO4 (525.4757)


   

14-Methyltetracosanoylcarnitine

14-Methyltetracosanoylcarnitine

C32H63NO4 (525.4757)


   

18-Methyltetracosanoylcarnitine

18-Methyltetracosanoylcarnitine

C32H63NO4 (525.4757)


   

11-Methyltetracosanoylcarnitine

11-Methyltetracosanoylcarnitine

C32H63NO4 (525.4757)


   

12-Methyltetracosanoylcarnitine

12-Methyltetracosanoylcarnitine

C32H63NO4 (525.4757)


   

N-hexadecanoyl-15-methylhexadecasphinganine

N-hexadecanoyl-15-methylhexadecasphinganine

C33H67NO3 (525.5121)


   

(21Z,24Z,27Z,30Z,33Z)-hexatriacontapentaenoate

(21Z,24Z,27Z,30Z,33Z)-hexatriacontapentaenoate

C36H61O2- (525.4671)


A hexatriacontapentaenoate that is the conjugate base of (21Z,24Z,27Z,30Z,33Z)-hexatriacontapentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(18Z,21Z,24Z,27Z,30Z)-hexatriacontapentaenoate

(18Z,21Z,24Z,27Z,30Z)-hexatriacontapentaenoate

C36H61O2- (525.4671)


A polyunsaturated fatty acid anion that is the conjugate base of (18Z,21Z,24Z,27Z,30Z)-hexatriacontapentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

N-(1,3-dihydroxyoctadecan-2-yl)pentadecanamide

N-(1,3-dihydroxyoctadecan-2-yl)pentadecanamide

C33H67NO3 (525.5121)


   

N-(1,3-dihydroxyhexadecan-2-yl)heptadecanamide

N-(1,3-dihydroxyhexadecan-2-yl)heptadecanamide

C33H67NO3 (525.5121)


   

NAGly 13:0/16:0

NAGly 13:0/16:0

C31H59NO5 (525.4393)


   

NAGly 11:0/18:0

NAGly 11:0/18:0

C31H59NO5 (525.4393)


   

NAGly 12:0/17:0

NAGly 12:0/17:0

C31H59NO5 (525.4393)


   

NAGly 16:0/13:0

NAGly 16:0/13:0

C31H59NO5 (525.4393)


   

NAGly 10:0/19:0

NAGly 10:0/19:0

C31H59NO5 (525.4393)


   

NAGly 14:0/15:0

NAGly 14:0/15:0

C31H59NO5 (525.4393)


   

NAGly 15:0/14:0

NAGly 15:0/14:0

C31H59NO5 (525.4393)


   

NAGly 19:0/10:0

NAGly 19:0/10:0

C31H59NO5 (525.4393)


   

NAGly 17:0/12:0

NAGly 17:0/12:0

C31H59NO5 (525.4393)


   

NAGly 18:0/11:0

NAGly 18:0/11:0

C31H59NO5 (525.4393)


   

N-(1,3-dihydroxynonan-2-yl)tetracosanamide

N-(1,3-dihydroxynonan-2-yl)tetracosanamide

C33H67NO3 (525.5121)


   

N-(1,3-dihydroxypentacosan-2-yl)octanamide

N-(1,3-dihydroxypentacosan-2-yl)octanamide

C33H67NO3 (525.5121)


   

N-(1,3-dihydroxyhentriacontan-2-yl)acetamide

N-(1,3-dihydroxyhentriacontan-2-yl)acetamide

C33H67NO3 (525.5121)


   

N-(1,3-dihydroxytriacontan-2-yl)propanamide

N-(1,3-dihydroxytriacontan-2-yl)propanamide

C33H67NO3 (525.5121)


   

N-(1,3-dihydroxyheptacosan-2-yl)hexanamide

N-(1,3-dihydroxyheptacosan-2-yl)hexanamide

C33H67NO3 (525.5121)


   

N-(1,3-dihydroxyhexacosan-2-yl)heptanamide

N-(1,3-dihydroxyhexacosan-2-yl)heptanamide

C33H67NO3 (525.5121)


   

N-(1,3-dihydroxyoctan-2-yl)pentacosanamide

N-(1,3-dihydroxyoctan-2-yl)pentacosanamide

C33H67NO3 (525.5121)


   

N-(1,3-dihydroxyoctacosan-2-yl)pentanamide

N-(1,3-dihydroxyoctacosan-2-yl)pentanamide

C33H67NO3 (525.5121)


   

N-(1,3-dihydroxytetracosan-2-yl)nonanamide

N-(1,3-dihydroxytetracosan-2-yl)nonanamide

C33H67NO3 (525.5121)


   

N-(1,3-dihydroxynonacosan-2-yl)butanamide

N-(1,3-dihydroxynonacosan-2-yl)butanamide

C33H67NO3 (525.5121)


   

N-(1,3-dihydroxytridecan-2-yl)icosanamide

N-(1,3-dihydroxytridecan-2-yl)icosanamide

C33H67NO3 (525.5121)


   

N-(1,3-dihydroxytricosan-2-yl)decanamide

N-(1,3-dihydroxytricosan-2-yl)decanamide

C33H67NO3 (525.5121)


   

N-(1,3-dihydroxydodecan-2-yl)henicosanamide

N-(1,3-dihydroxydodecan-2-yl)henicosanamide

C33H67NO3 (525.5121)


   

N-(1,3-dihydroxyundecan-2-yl)docosanamide

N-(1,3-dihydroxyundecan-2-yl)docosanamide

C33H67NO3 (525.5121)


   

N-(1,3-dihydroxydecan-2-yl)tricosanamide

N-(1,3-dihydroxydecan-2-yl)tricosanamide

C33H67NO3 (525.5121)


   

N-(1,3-dihydroxydocosan-2-yl)undecanamide

N-(1,3-dihydroxydocosan-2-yl)undecanamide

C33H67NO3 (525.5121)


   

Cer 9:0;3O/22:2;(2OH)

Cer 9:0;3O/22:2;(2OH)

C31H59NO5 (525.4393)


   

Cer 11:0;3O/20:2;(2OH)

Cer 11:0;3O/20:2;(2OH)

C31H59NO5 (525.4393)


   

Cer 13:0;3O/18:2;(2OH)

Cer 13:0;3O/18:2;(2OH)

C31H59NO5 (525.4393)


   

Cer 13:1;3O/18:1;(2OH)

Cer 13:1;3O/18:1;(2OH)

C31H59NO5 (525.4393)


   

Cer 12:1;3O/19:1;(2OH)

Cer 12:1;3O/19:1;(2OH)

C31H59NO5 (525.4393)


   

N-(1,3-dihydroxynonadecan-2-yl)tetradecanamide

N-(1,3-dihydroxynonadecan-2-yl)tetradecanamide

C33H67NO3 (525.5121)


   

N-(1,3-dihydroxytetradecan-2-yl)nonadecanamide

N-(1,3-dihydroxytetradecan-2-yl)nonadecanamide

C33H67NO3 (525.5121)


   

N-(1,3-dihydroxypentadecan-2-yl)octadecanamide

N-(1,3-dihydroxypentadecan-2-yl)octadecanamide

C33H67NO3 (525.5121)


   

N-(1,3-dihydroxyheptadecan-2-yl)hexadecanamide

N-(1,3-dihydroxyheptadecan-2-yl)hexadecanamide

C33H67NO3 (525.5121)


   

N-(1,3-dihydroxyicosan-2-yl)tridecanamide

N-(1,3-dihydroxyicosan-2-yl)tridecanamide

C33H67NO3 (525.5121)


   

N-(1,3-dihydroxyhenicosan-2-yl)dodecanamide

N-(1,3-dihydroxyhenicosan-2-yl)dodecanamide

C33H67NO3 (525.5121)


   

N-[(E)-1,3,4-trihydroxypentadec-8-en-2-yl]heptadecanamide

N-[(E)-1,3,4-trihydroxypentadec-8-en-2-yl]heptadecanamide

C32H63NO4 (525.4757)


   

N-[(E)-1,3,4-trihydroxyicos-8-en-2-yl]dodecanamide

N-[(E)-1,3,4-trihydroxyicos-8-en-2-yl]dodecanamide

C32H63NO4 (525.4757)


   

N-[(E)-1,3,4-trihydroxyoctadec-8-en-2-yl]tetradecanamide

N-[(E)-1,3,4-trihydroxyoctadec-8-en-2-yl]tetradecanamide

C32H63NO4 (525.4757)


   

(Z)-N-(1,3,4-trihydroxyheptadecan-2-yl)pentadec-9-enamide

(Z)-N-(1,3,4-trihydroxyheptadecan-2-yl)pentadec-9-enamide

C32H63NO4 (525.4757)


   

N-[(E)-1,3,4-trihydroxyheptadec-8-en-2-yl]pentadecanamide

N-[(E)-1,3,4-trihydroxyheptadec-8-en-2-yl]pentadecanamide

C32H63NO4 (525.4757)


   

(Z)-N-(1,3,4-trihydroxyhexadecan-2-yl)hexadec-7-enamide

(Z)-N-(1,3,4-trihydroxyhexadecan-2-yl)hexadec-7-enamide

C32H63NO4 (525.4757)


   

(Z)-N-(1,3,4-trihydroxytetradecan-2-yl)octadec-11-enamide

(Z)-N-(1,3,4-trihydroxytetradecan-2-yl)octadec-11-enamide

C32H63NO4 (525.4757)


   

(Z)-N-(1,3,4-trihydroxyicosan-2-yl)dodec-5-enamide

(Z)-N-(1,3,4-trihydroxyicosan-2-yl)dodec-5-enamide

C32H63NO4 (525.4757)


   

(Z)-N-(1,3,4-trihydroxynonadecan-2-yl)tridec-8-enamide

(Z)-N-(1,3,4-trihydroxynonadecan-2-yl)tridec-8-enamide

C32H63NO4 (525.4757)


   

N-[(E)-1,3,4-trihydroxytetradec-8-en-2-yl]octadecanamide

N-[(E)-1,3,4-trihydroxytetradec-8-en-2-yl]octadecanamide

C32H63NO4 (525.4757)


   

(Z)-N-(1,3,4-trihydroxyoctadecan-2-yl)tetradec-9-enamide

(Z)-N-(1,3,4-trihydroxyoctadecan-2-yl)tetradec-9-enamide

C32H63NO4 (525.4757)


   

N-[(E)-1,3,4-trihydroxyhexadec-8-en-2-yl]hexadecanamide

N-[(E)-1,3,4-trihydroxyhexadec-8-en-2-yl]hexadecanamide

C32H63NO4 (525.4757)


   

N-[(E)-1,3,4-trihydroxynonadec-8-en-2-yl]tridecanamide

N-[(E)-1,3,4-trihydroxynonadec-8-en-2-yl]tridecanamide

C32H63NO4 (525.4757)


   

Cer 14:1;2O/18:0;(3OH)

Cer 14:1;2O/18:0;(3OH)

C32H63NO4 (525.4757)


   

Cer 15:1;2O/17:0;(2OH)

Cer 15:1;2O/17:0;(2OH)

C32H63NO4 (525.4757)


   

Cer 17:1;2O/15:0;(2OH)

Cer 17:1;2O/15:0;(2OH)

C32H63NO4 (525.4757)


   

Cer 14:0;2O/18:1;(2OH)

Cer 14:0;2O/18:1;(2OH)

C32H63NO4 (525.4757)


   

Cer 16:0;2O/16:1;(2OH)

Cer 16:0;2O/16:1;(2OH)

C32H63NO4 (525.4757)


   

Cer 19:2;3O/12:0;(2OH)

Cer 19:2;3O/12:0;(2OH)

C31H59NO5 (525.4393)


   

Cer 14:2;3O/17:0;(2OH)

Cer 14:2;3O/17:0;(2OH)

C31H59NO5 (525.4393)


   

Cer 19:1;2O/13:0;(3OH)

Cer 19:1;2O/13:0;(3OH)

C32H63NO4 (525.4757)


   

Cer 18:1;2O/14:0;(3OH)

Cer 18:1;2O/14:0;(3OH)

C32H63NO4 (525.4757)


   

Cer 14:1;2O/18:0;(2OH)

Cer 14:1;2O/18:0;(2OH)

C32H63NO4 (525.4757)


   

Cer 17:1;3O/14:1;(2OH)

Cer 17:1;3O/14:1;(2OH)

C31H59NO5 (525.4393)


   

Cer 17:2;3O/14:0;(2OH)

Cer 17:2;3O/14:0;(2OH)

C31H59NO5 (525.4393)


   

Cer 18:2;3O/13:0;(2OH)

Cer 18:2;3O/13:0;(2OH)

C31H59NO5 (525.4393)


   

Cer 18:0;2O/14:1;(2OH)

Cer 18:0;2O/14:1;(2OH)

C32H63NO4 (525.4757)


   

Cer 17:1;2O/15:0;(3OH)

Cer 17:1;2O/15:0;(3OH)

C32H63NO4 (525.4757)


   

Cer 18:1;3O/13:1;(2OH)

Cer 18:1;3O/13:1;(2OH)

C31H59NO5 (525.4393)


   

Cer 16:2;3O/15:0;(2OH)

Cer 16:2;3O/15:0;(2OH)

C31H59NO5 (525.4393)


   

Cer 19:1;3O/12:1;(2OH)

Cer 19:1;3O/12:1;(2OH)

C31H59NO5 (525.4393)


   

Cer 20:0;2O/12:1;(3OH)

Cer 20:0;2O/12:1;(3OH)

C32H63NO4 (525.4757)


   

Cer 15:2;3O/16:0;(2OH)

Cer 15:2;3O/16:0;(2OH)

C31H59NO5 (525.4393)


   

Cer 20:1;2O/12:0;(3OH)

Cer 20:1;2O/12:0;(3OH)

C32H63NO4 (525.4757)


   

Cer 18:1;2O/14:0;(2OH)

Cer 18:1;2O/14:0;(2OH)

C32H63NO4 (525.4757)


   

Cer 15:1;3O/16:1;(2OH)

Cer 15:1;3O/16:1;(2OH)

C31H59NO5 (525.4393)


   

Cer 15:0;3O/16:2;(2OH)

Cer 15:0;3O/16:2;(2OH)

C31H59NO5 (525.4393)


   

Cer 19:0;2O/13:1;(2OH)

Cer 19:0;2O/13:1;(2OH)

C32H63NO4 (525.4757)


   

Cer 15:1;2O/17:0;(3OH)

Cer 15:1;2O/17:0;(3OH)

C32H63NO4 (525.4757)


   

Cer 16:1;2O/16:0;(2OH)

Cer 16:1;2O/16:0;(2OH)

C32H63NO4 (525.4757)


   

Cer 16:1;3O/15:1;(2OH)

Cer 16:1;3O/15:1;(2OH)

C31H59NO5 (525.4393)


   

Cer 19:1;2O/13:0;(2OH)

Cer 19:1;2O/13:0;(2OH)

C32H63NO4 (525.4757)


   

Cer 16:0;2O/16:1;(3OH)

Cer 16:0;2O/16:1;(3OH)

C32H63NO4 (525.4757)


   

Cer 17:0;2O/15:1;(3OH)

Cer 17:0;2O/15:1;(3OH)

C32H63NO4 (525.4757)


   

Cer 17:0;2O/15:1;(2OH)

Cer 17:0;2O/15:1;(2OH)

C32H63NO4 (525.4757)


   

Cer 14:0;2O/18:1;(3OH)

Cer 14:0;2O/18:1;(3OH)

C32H63NO4 (525.4757)


   

Cer 18:0;2O/14:1;(3OH)

Cer 18:0;2O/14:1;(3OH)

C32H63NO4 (525.4757)


   

Cer 20:1;2O/12:0;(2OH)

Cer 20:1;2O/12:0;(2OH)

C32H63NO4 (525.4757)


   

Cer 16:1;2O/16:0;(3OH)

Cer 16:1;2O/16:0;(3OH)

C32H63NO4 (525.4757)


   

Cer 20:0;2O/12:1;(2OH)

Cer 20:0;2O/12:1;(2OH)

C32H63NO4 (525.4757)


   

Cer 19:0;2O/13:1;(3OH)

Cer 19:0;2O/13:1;(3OH)

C32H63NO4 (525.4757)


   

N-(tridecanoyl)-eicosasphinganine

N-(tridecanoyl)-eicosasphinganine

C33H67NO3 (525.5121)


   

N-(hexadecanoyl)-heptadecasphinganine

N-(hexadecanoyl)-heptadecasphinganine

C33H67NO3 (525.5121)


   

N-(dodecanoyl)-heneicosasphinganine

N-(dodecanoyl)-heneicosasphinganine

C33H67NO3 (525.5121)


   

N-(octadecanoyl)-pentadecasphinganine

N-(octadecanoyl)-pentadecasphinganine

C33H67NO3 (525.5121)


   

N-(nonadecanoyl)-tetradecasphinganine

N-(nonadecanoyl)-tetradecasphinganine

C33H67NO3 (525.5121)


   

N-(tetradecanoyl)-nonadecasphinganine

N-(tetradecanoyl)-nonadecasphinganine

C33H67NO3 (525.5121)


   

N-(heptadecanoyl)-hexadecasphinganine

N-(heptadecanoyl)-hexadecasphinganine

C33H67NO3 (525.5121)


   

N-(pentadecanoyl)-sphinganine

N-(pentadecanoyl)-sphinganine

C33H67NO3 (525.5121)


   

hexatriacontapentaenoate

hexatriacontapentaenoate

C36H61O2 (525.4671)


A polyunsaturated fatty acid anion that is the conjugate base of hexatriacontapentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   
   
   
   

Cer 14:1;O2/18:0;2OH

Cer 14:1;O2/18:0;2OH

C32H63NO4 (525.4757)


   

Cer 14:1;O2/18:0;3OH

Cer 14:1;O2/18:0;3OH

C32H63NO4 (525.4757)


   

Cer 14:1;O2/18:0;O

Cer 14:1;O2/18:0;O

C32H63NO4 (525.4757)


   

Cer 15:1;O2/17:0;2OH

Cer 15:1;O2/17:0;2OH

C32H63NO4 (525.4757)


   

Cer 15:1;O2/17:0;3OH

Cer 15:1;O2/17:0;3OH

C32H63NO4 (525.4757)


   

Cer 15:1;O2/17:0;O

Cer 15:1;O2/17:0;O

C32H63NO4 (525.4757)


   

Cer 16:1;O2/16:0;2OH

Cer 16:1;O2/16:0;2OH

C32H63NO4 (525.4757)


   

Cer 16:1;O2/16:0;3OH

Cer 16:1;O2/16:0;3OH

C32H63NO4 (525.4757)


   

Cer 16:1;O2/16:0;O

Cer 16:1;O2/16:0;O

C32H63NO4 (525.4757)


   

Cer 17:1;O2/15:0;2OH

Cer 17:1;O2/15:0;2OH

C32H63NO4 (525.4757)


   

Cer 17:1;O2/15:0;3OH

Cer 17:1;O2/15:0;3OH

C32H63NO4 (525.4757)


   

Cer 17:1;O2/15:0;O

Cer 17:1;O2/15:0;O

C32H63NO4 (525.4757)


   

Cer 18:1;O2/14:0;2OH

Cer 18:1;O2/14:0;2OH

C32H63NO4 (525.4757)


   

Cer 18:1;O2/14:0;3OH

Cer 18:1;O2/14:0;3OH

C32H63NO4 (525.4757)


   

Cer 18:1;O2/14:0;O

Cer 18:1;O2/14:0;O

C32H63NO4 (525.4757)


   

Cer 19:1;O2/13:0;2OH

Cer 19:1;O2/13:0;2OH

C32H63NO4 (525.4757)


   

Cer 19:1;O2/13:0;3OH

Cer 19:1;O2/13:0;3OH

C32H63NO4 (525.4757)


   

Cer 19:1;O2/13:0;O

Cer 19:1;O2/13:0;O

C32H63NO4 (525.4757)


   

Cer 20:1;O2/12:0;2OH

Cer 20:1;O2/12:0;2OH

C32H63NO4 (525.4757)


   

Cer 20:1;O2/12:0;3OH

Cer 20:1;O2/12:0;3OH

C32H63NO4 (525.4757)


   

Cer 20:1;O2/12:0;O

Cer 20:1;O2/12:0;O

C32H63NO4 (525.4757)


   

Cer 21:1;O2/11:0;2OH

Cer 21:1;O2/11:0;2OH

C32H63NO4 (525.4757)


   

Cer 21:1;O2/11:0;3OH

Cer 21:1;O2/11:0;3OH

C32H63NO4 (525.4757)


   

Cer 21:1;O2/11:0;O

Cer 21:1;O2/11:0;O

C32H63NO4 (525.4757)


   

Cer 22:1;O2/10:0;2OH

Cer 22:1;O2/10:0;2OH

C32H63NO4 (525.4757)


   

Cer 22:1;O2/10:0;3OH

Cer 22:1;O2/10:0;3OH

C32H63NO4 (525.4757)


   

Cer 22:1;O2/10:0;O

Cer 22:1;O2/10:0;O

C32H63NO4 (525.4757)


   

Cer 14:0;O2/18:1;2OH

Cer 14:0;O2/18:1;2OH

C32H63NO4 (525.4757)


   

Cer 14:0;O2/18:1;3OH

Cer 14:0;O2/18:1;3OH

C32H63NO4 (525.4757)


   

Cer 14:0;O2/18:1;O

Cer 14:0;O2/18:1;O

C32H63NO4 (525.4757)


   

Cer 14:0;O2/19:0

Cer 14:0;O2/19:0

C33H67NO3 (525.5121)


   

Cer 15:0;O2/18:0

Cer 15:0;O2/18:0

C33H67NO3 (525.5121)


   

Cer 16:0;O2/17:0

Cer 16:0;O2/17:0

C33H67NO3 (525.5121)


   

Cer 17:0;O2/16:0

Cer 17:0;O2/16:0

C33H67NO3 (525.5121)


   

Cer 18:0;O2/15:0

Cer 18:0;O2/15:0

C33H67NO3 (525.5121)


   

Cer 19:0;O2/14:0

Cer 19:0;O2/14:0

C33H67NO3 (525.5121)


   

Cer 20:0;O2/13:0

Cer 20:0;O2/13:0

C33H67NO3 (525.5121)


   

Cer 21:0;O2/12:0

Cer 21:0;O2/12:0

C33H67NO3 (525.5121)


   

Cer 22:0;O2/11:0

Cer 22:0;O2/11:0

C33H67NO3 (525.5121)


   

Cer 9:0;O3/22:2;O

Cer 9:0;O3/22:2;O

C31H59NO5 (525.4393)


   

Cer 14:0;O3/18:1

Cer 14:0;O3/18:1

C32H63NO4 (525.4757)


   

Cer 15:0;O3/17:1

Cer 15:0;O3/17:1

C32H63NO4 (525.4757)


   

Cer 16:0;O3/16:1

Cer 16:0;O3/16:1

C32H63NO4 (525.4757)


   

Cer 17:0;O3/15:1

Cer 17:0;O3/15:1

C32H63NO4 (525.4757)


   

Cer 18:0;O3/14:1

Cer 18:0;O3/14:1

C32H63NO4 (525.4757)